首页 > 最新文献

Lancet Regional Health-Americas最新文献

英文 中文
US emergency department visits by women due to assault (2018–2021): a retrospective cross-sectional analysis 2018-2021年美国女性因性侵就诊急诊:回顾性横断面分析
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-06 DOI: 10.1016/j.lana.2025.101343
Summer Chavez , Irma Ugalde , Michael Ulrich , Omolola Adepoju , Tonghui Xu , Winston Liaw

Background

Domestic violence has played a key role in linking firearms and homicide amongst female individuals. Combined with the increase of reports of violence against women during the COVID-19 pandemic, a rise in emergency department (ED) visits may be witnessed. Our aim was to estimate the changes in prevalence and risk factors associated with assault and firearm-related emergency department (ED) visits by female patients following the COVID-19 pandemic.

Methods

We performed a retrospective cross-sectional study of female patients presenting to EDs due to assault from the National Emergency Department Sample (NEDS) from 2018 to 2021. Independent variables included age, race, mortality, ED disposition, primary payer, location, mean total ED chargers, quartile ZIP income, and mechanism and intent of injury. The adjusted association between independent variables and ED visits among patients injured by firearms compared to those injured by other assaults was examined.

Findings

The analytic sample represented an estimated 1,575,543 ED weighted records of female assault cases out of a total weighted sample of 537,133,200 observations (0.29%). While year-over-year ED encounters decreased, firearm injuries and the proportion of patients admitted and dying in the hospital increased. Female patients who were injured by firearms had 89 times higher risk of dying in the ED (RR = 88.82; 95% CI 6 = 72.38–97.06) compared to female patients injured by non-firearm injury mechanisms. Racial disparities were prevalent, with Native American women experiencing the greatest risk of being assaulted (RR = 2.81; 95% CI 2.67–2.97). Victims of firearm related assaults had nearly 4.12 times the risk of identifying as Black compared with those assaulted without firearms (95% CI 3.75–4.52). Female patients seeking care for assault had higher risk of being uninsured (95% CI 2.70–2.77).

Interpretation

While year-over-year ED encounters due to assault decreased, lockdowns and restrictions associated with the observed COVID-19 pandemic may not fully reflect changes in abuse rates in this time period. The strong connection between firearm presence and female homicide and continuations of assault and firearm-related ED visits among vulnerable demographic groups highlights the need for effective strategies to reduce violence.

Funding

Unfunded.
家庭暴力在将枪支与女性杀人联系起来方面发挥了关键作用。在2019冠状病毒病大流行期间,暴力侵害妇女行为的报告有所增加,因此急诊就诊人数可能会增加。我们的目的是估计2019冠状病毒病大流行后女性患者攻击和枪支相关急诊科(ED)就诊的患病率和风险因素的变化。方法:我们对2018年至2021年国家急诊科样本(NEDS)中因攻击而就诊的女性患者进行了回顾性横断面研究。独立变量包括年龄、种族、死亡率、急症处置、主要付款人、地点、平均急症总收费人、四分位数ZIP收入、机制和伤害意图。与其他袭击受伤的患者相比,受火器伤害的患者与急诊室就诊之间的调整后的自变量之间的关联进行了检查。分析样本代表了537,133,200个观察的总加权样本(0.29%)中约1,575,543个女性性侵案件的ED加权记录。虽然急诊病例逐年减少,但火器伤害以及住院和死亡的患者比例却有所增加。女性火器伤患者急诊死亡风险是非火器伤女性患者的89倍(RR = 88.82; 95% CI 6 = 72.38 ~ 97.06)。种族差异普遍存在,美洲原住民妇女遭受侵犯的风险最大(RR = 2.81; 95% CI 2.67-2.97)。与没有枪支的受害者相比,枪支相关袭击的受害者被认定为黑人的风险近4.12倍(95% CI 3.75-4.52)。因遭受袭击而寻求治疗的女性患者没有保险的风险更高(95% CI 2.70-2.77)。虽然因袭击而导致的急诊事件逐年减少,但与观察到的COVID-19大流行相关的封锁和限制可能无法完全反映这一时期虐待率的变化。在弱势群体中,枪支的存在与女性杀人、持续的攻击和与枪支有关的急诊科就诊之间存在着密切的联系,这突出表明需要制定有效的战略来减少暴力。
{"title":"US emergency department visits by women due to assault (2018–2021): a retrospective cross-sectional analysis","authors":"Summer Chavez ,&nbsp;Irma Ugalde ,&nbsp;Michael Ulrich ,&nbsp;Omolola Adepoju ,&nbsp;Tonghui Xu ,&nbsp;Winston Liaw","doi":"10.1016/j.lana.2025.101343","DOIUrl":"10.1016/j.lana.2025.101343","url":null,"abstract":"<div><h3>Background</h3><div>Domestic violence has played a key role in linking firearms and homicide amongst female individuals. Combined with the increase of reports of violence against women during the COVID-19 pandemic, a rise in emergency department (ED) visits may be witnessed. Our aim was to estimate the changes in prevalence and risk factors associated with assault and firearm-related emergency department (ED) visits by female patients following the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>We performed a retrospective cross-sectional study of female patients presenting to EDs due to assault from the National Emergency Department Sample (NEDS) from 2018 to 2021. Independent variables included age, race, mortality, ED disposition, primary payer, location, mean total ED chargers, quartile ZIP income, and mechanism and intent of injury. The adjusted association between independent variables and ED visits among patients injured by firearms compared to those injured by other assaults was examined.</div></div><div><h3>Findings</h3><div>The analytic sample represented an estimated 1,575,543 ED weighted records of female assault cases out of a total weighted sample of 537,133,200 observations (0.29%). While year-over-year ED encounters decreased, firearm injuries and the proportion of patients admitted and dying in the hospital increased. Female patients who were injured by firearms had 89 times higher risk of dying in the ED (RR = 88.82; 95% CI 6 = 72.38–97.06) compared to female patients injured by non-firearm injury mechanisms. Racial disparities were prevalent, with Native American women experiencing the greatest risk of being assaulted (RR = 2.81; 95% CI 2.67–2.97). Victims of firearm related assaults had nearly 4.12 times the risk of identifying as Black compared with those assaulted without firearms (95% CI 3.75–4.52). Female patients seeking care for assault had higher risk of being uninsured (95% CI 2.70–2.77).</div></div><div><h3>Interpretation</h3><div>While year-over-year ED encounters due to assault decreased, lockdowns and restrictions associated with the observed COVID-19 pandemic may not fully reflect changes in abuse rates in this time period. The strong connection between firearm presence and female homicide and continuations of assault and firearm-related ED visits among vulnerable demographic groups highlights the need for effective strategies to reduce violence.</div></div><div><h3>Funding</h3><div>Unfunded.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101343"},"PeriodicalIF":7.0,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brazil's health tax at a crossroads: safeguarding the constitutional victory against ultra-processed foods 巴西的健康税正处于十字路口:捍卫反对超加工食品的宪法胜利
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-02 DOI: 10.1016/j.lana.2025.101363
Felipe Silva Neves , Larissa Loures Mendes , Eduardo Augusto Fernandes Nilson , Inês Rugani Ribeiro de Castro , Rafael Moreira Claro , Daniela Silva Canella , Ísis Eloah Machado , Ariene Silva do Carmo , Mariana Carvalho de Menezes , Deborah Carvalho Malta
{"title":"Brazil's health tax at a crossroads: safeguarding the constitutional victory against ultra-processed foods","authors":"Felipe Silva Neves ,&nbsp;Larissa Loures Mendes ,&nbsp;Eduardo Augusto Fernandes Nilson ,&nbsp;Inês Rugani Ribeiro de Castro ,&nbsp;Rafael Moreira Claro ,&nbsp;Daniela Silva Canella ,&nbsp;Ísis Eloah Machado ,&nbsp;Ariene Silva do Carmo ,&nbsp;Mariana Carvalho de Menezes ,&nbsp;Deborah Carvalho Malta","doi":"10.1016/j.lana.2025.101363","DOIUrl":"10.1016/j.lana.2025.101363","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101363"},"PeriodicalIF":7.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond encampments: an evidence-based path to solving Canada's homelessness crisis 超越营地:解决加拿大无家可归危机的循证之路
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-02 DOI: 10.1016/j.lana.2025.101362
Mohammad Karamouzian , Stephen W. Hwang , Dan Werb
{"title":"Beyond encampments: an evidence-based path to solving Canada's homelessness crisis","authors":"Mohammad Karamouzian ,&nbsp;Stephen W. Hwang ,&nbsp;Dan Werb","doi":"10.1016/j.lana.2025.101362","DOIUrl":"10.1016/j.lana.2025.101362","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101362"},"PeriodicalIF":7.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlines 在最近一次戒烟尝试失败后,电子烟与联合尼古丁替代疗法:一项通过州烟草戒烟热线进行的实用随机试验
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-02 DOI: 10.1016/j.lana.2025.101351
Theodore L. Wagener , Alice Hinton , Theodore M. Brasky , Yoo Jin Cho , Laura A. Beebe , Michael S. Businelle , Matthew J. Carpenter , Jonathan Hart , Katrina A. Vickerman

Background

E-cigarettes have emerged as a potentially more effective and satisfying alternative to nicotine replacement therapy (NRT) for smokers who struggle to quit. Although quitlines are effective platforms for tobacco cessation, they have not incorporated e-cigarettes due to regulatory concerns and limited clinical evidence. We evaluated whether quitline-delivered counseling combined with e-cigarettes was more effective than counseling with NRT among adults who recently failed to quit using standard quitline services.

Methods

We conducted a pragmatic, open-label, parallel-group randomised controlled trial with two U.S. state quitlines between October 2020 and January 2023. Adults [N = 350; 212 (61%) female & 248 (72%) white] who were still smoking after a recent quitline enrollment were randomised (1:1) to receive 8 weeks of either JUUL e-cigarettes or a combination of nicotine patch and lozenge, along with three counseling calls. The primary outcome was biochemically verified 7-day point prevalence smoking abstinence (7-day PPA) at 8 weeks. Analyses used an intent-to-treat approach; secondary outcomes included 12-week abstinence, prolonged abstinence, changes in smoking behavior, dependence, and adverse effects.

Findings

At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80–3.04; p = 0.19]. Both groups showed similar reductions in cigarette use and dependence. Adherence to counseling and assigned products was high. Adverse events were generally mild; cough and breathing difficulties were more frequently reported in the e-cigarette group and NRT participants reported more dizziness, sleeplessness, and allergies.

Interpretation

Among quitline users with a recent failed quit attempt, e-cigarettes combined with quitline counseling were not more effective than combination NRT in increasing smoking abstinence after 8 weeks’ follow-up.

Funding

U.S. National Institute on Drug Abuse.
对于那些努力戒烟的人来说,de -香烟已经成为尼古丁替代疗法(NRT)潜在的更有效、更令人满意的替代品。虽然戒烟热线是戒烟的有效平台,但由于监管方面的考虑和有限的临床证据,它们并没有纳入电子烟。我们评估了在最近使用标准戒烟热线服务戒烟失败的成年人中,戒烟热线提供的咨询与电子烟结合是否比NRT更有效。方法:我们在2020年10月至2023年1月期间对美国两条州戒烟线进行了一项实用、开放标签、平行组随机对照试验。成人[N = 350;在最近的戒烟热线登记后,仍在吸烟的212名(61%)女性(248名(72%)白人)被随机分成(1:1)组,接受8周的JUUL电子烟或尼古丁贴片和锭剂的组合,同时还有3个咨询电话。主要终点是8周时经生化验证的7天点流行戒烟(7天PPA)。分析采用意向治疗法;次要结局包括12周戒烟、长期戒烟、吸烟行为的改变、依赖和不良反应。结果发现,在8周,7天的PPA在电子烟组和NRT组之间没有显著差异[175人中分别有25人(14.3%)和17人(9.7%);或1.56;95% ci 0.80-3.04;P = 0.19]。两组人在吸烟和对香烟的依赖方面都有相似的减少。对咨询和指定产品的依从性很高。不良事件一般轻微;电子烟组更频繁地报告咳嗽和呼吸困难,NRT参与者报告更多的头晕、失眠和过敏。解释:在最近戒烟失败的戒烟热线使用者中,经过8周的随访,电子烟联合戒烟热线咨询在增加戒烟方面并不比联合NRT更有效。国家药物滥用研究所。
{"title":"E-cigarettes versus combination nicotine replacement therapy following a recent failed quit attempt: a pragmatic randomized trial through state tobacco quitlines","authors":"Theodore L. Wagener ,&nbsp;Alice Hinton ,&nbsp;Theodore M. Brasky ,&nbsp;Yoo Jin Cho ,&nbsp;Laura A. Beebe ,&nbsp;Michael S. Businelle ,&nbsp;Matthew J. Carpenter ,&nbsp;Jonathan Hart ,&nbsp;Katrina A. Vickerman","doi":"10.1016/j.lana.2025.101351","DOIUrl":"10.1016/j.lana.2025.101351","url":null,"abstract":"<div><h3>Background</h3><div>E-cigarettes have emerged as a potentially more effective and satisfying alternative to nicotine replacement therapy (NRT) for smokers who struggle to quit. Although quitlines are effective platforms for tobacco cessation, they have not incorporated e-cigarettes due to regulatory concerns and limited clinical evidence. We evaluated whether quitline-delivered counseling combined with e-cigarettes was more effective than counseling with NRT among adults who recently failed to quit using standard quitline services.</div></div><div><h3>Methods</h3><div>We conducted a pragmatic, open-label, parallel-group randomised controlled trial with two U.S. state quitlines between October 2020 and January 2023. Adults [N = 350; 212 (61%) female &amp; 248 (72%) white] who were still smoking after a recent quitline enrollment were randomised (1:1) to receive 8 weeks of either JUUL e-cigarettes or a combination of nicotine patch and lozenge, along with three counseling calls. The primary outcome was biochemically verified 7-day point prevalence smoking abstinence (7-day PPA) at 8 weeks. Analyses used an intent-to-treat approach; secondary outcomes included 12-week abstinence, prolonged abstinence, changes in smoking behavior, dependence, and adverse effects.</div></div><div><h3>Findings</h3><div>At 8 weeks, 7-day PPA did not differ significantly between e-cigarette and NRT groups [25 (14.3%) of 175 and 17 (9.7%) of 175, respectively; OR 1.56; 95% CI 0.80–3.04; p = 0.19]. Both groups showed similar reductions in cigarette use and dependence. Adherence to counseling and assigned products was high. Adverse events were generally mild; cough and breathing difficulties were more frequently reported in the e-cigarette group and NRT participants reported more dizziness, sleeplessness, and allergies.</div></div><div><h3>Interpretation</h3><div>Among quitline users with a recent failed quit attempt, e-cigarettes combined with quitline counseling were not more effective than combination NRT in increasing smoking abstinence after 8 weeks’ follow-up.</div></div><div><h3>Funding</h3><div>U.S. <span>National Institute on Drug Abuse</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101351"},"PeriodicalIF":7.0,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145884386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unique role of the prospective cohort incident-tumor biobank method in etiological research 前瞻性队列事件肿瘤生物库方法在病因学研究中的独特作用
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lana.2025.101290
Shuji Ogino , Alpa V. Patel , Satoko Ugai , Marios Giannakis , Tomotaka Ugai
{"title":"Unique role of the prospective cohort incident-tumor biobank method in etiological research","authors":"Shuji Ogino ,&nbsp;Alpa V. Patel ,&nbsp;Satoko Ugai ,&nbsp;Marios Giannakis ,&nbsp;Tomotaka Ugai","doi":"10.1016/j.lana.2025.101290","DOIUrl":"10.1016/j.lana.2025.101290","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101290"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncovering the post-pandemic timing of influenza, RSV, and COVID-19 driving seasonal influenza-like illness in the United States: a retrospective ecological study 揭示美国流感、RSV和COVID-19大流行后驱动季节性流感样疾病的时间:一项回顾性生态学研究
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lana.2025.101359
George Dewey , Austin G. Meyer , Raul Garrido Garcia , Mauricio Santillana

Background

Influenza and respiratory syncytial virus (RSV) are major contributors to the burden of seasonal influenza-like illnesses (ILI) in the US. The prevention and treatment of ILI varies substantially across age groups and in cost and administration schedule. This study aimed to characterize the timing and ordering of RSV, influenza, and COVID-19 epidemics in the post-pandemic period to inform public health preparedness.

Methods

We implemented a series of independent regression models to infer the contribution of each of these diseases to seasonal ILI syndromic indicators. We further implemented anomaly-detection algorithms on data from the US Centers for Disease Control and Prevention National Syndromic Surveillance Program for the 2022–23, 2023–24, and 2024–25 ILI seasons to identify the timing of onsets and peaks of RSV, influenza, and COVID-19.

Findings

A total of 148 state-ILI seasons were analyzed. In 114 out of 148 (77.0%) of analyzed seasons, volume of RSV emergency department (ED) visits peaked before influenza ED visits. The median time difference between peaks of RSV and peaks of influenza was +3.0 weeks (95% percentile range: −7.0, +7.0 weeks; interquartile range: 5.0 weeks). The timing of RSV and influenza onsets were found to occur more synchronously in the 2023–2024 and 2024–2025 ILI seasons. The timing of COVID-19 outbreaks did not show a consistent seasonal pattern across the study period.

Interpretation

RSV epidemics frequently reach peak volume before influenza epidemics across the US. Healthcare professionals and public health authorities should anticipate increases in RSV cases and hospitalizations at the start of the annual ILI season and establish infrastructure and planning to handle incoming surges of both RSV and influenza appropriately.

Funding

CDC Center for Forecasting and Outbreak Analytics; National Institutes of Health.
在美国,流感和呼吸道合胞病毒(RSV)是季节性流感样疾病(ILI)负担的主要贡献者。ILI的预防和治疗在不同年龄组、费用和管理时间表方面存在很大差异。本研究旨在描述大流行后时期RSV、流感和COVID-19流行的时间和顺序,为公共卫生准备提供信息。方法采用一系列独立回归模型,推断各疾病对季节性ILI证候指标的贡献。我们进一步对来自美国疾病控制和预防中心国家综合征监测计划的2022-23、2023-24和2024-25 ILI季节的数据实施了异常检测算法,以确定RSV、流感和COVID-19的发病时间和高峰。共分析了148个状态- ili季节。在148个分析季节中,有114个(77.0%)RSV急诊科的访问量在流感急诊科访问量之前达到高峰。RSV峰与流感峰的中位时差为+3.0周(95%百分位数范围:−7.0周,+7.0周;四分位数范围:5.0周)。发现RSV和流感发病时间在2023-2024年和2024-2025年流感流行季节更为同步。在整个研究期间,COVID-19爆发的时间没有显示出一致的季节性模式。rsv流行通常在美国流感流行之前达到高峰。卫生保健专业人员和公共卫生当局应在年度流感季节开始时预测到RSV病例和住院人数的增加,并建立基础设施和计划,以适当地处理RSV和流感的涌入。疾病预防控制中心预测和疫情分析中心;国立卫生研究院。
{"title":"Uncovering the post-pandemic timing of influenza, RSV, and COVID-19 driving seasonal influenza-like illness in the United States: a retrospective ecological study","authors":"George Dewey ,&nbsp;Austin G. Meyer ,&nbsp;Raul Garrido Garcia ,&nbsp;Mauricio Santillana","doi":"10.1016/j.lana.2025.101359","DOIUrl":"10.1016/j.lana.2025.101359","url":null,"abstract":"<div><h3>Background</h3><div>Influenza and respiratory syncytial virus (RSV) are major contributors to the burden of seasonal influenza-like illnesses (ILI) in the US. The prevention and treatment of ILI varies substantially across age groups and in cost and administration schedule. This study aimed to characterize the timing and ordering of RSV, influenza, and COVID-19 epidemics in the post-pandemic period to inform public health preparedness.</div></div><div><h3>Methods</h3><div>We implemented a series of independent regression models to infer the contribution of each of these diseases to seasonal ILI syndromic indicators. We further implemented anomaly-detection algorithms on data from the US Centers for Disease Control and Prevention National Syndromic Surveillance Program for the 2022–23, 2023–24, and 2024–25 ILI seasons to identify the timing of onsets and peaks of RSV, influenza, and COVID-19.</div></div><div><h3>Findings</h3><div>A total of 148 state-ILI seasons were analyzed. In 114 out of 148 (77.0%) of analyzed seasons, volume of RSV emergency department (ED) visits peaked before influenza ED visits. The median time difference between peaks of RSV and peaks of influenza was +3.0 weeks (95% percentile range: −7.0, +7.0 weeks; interquartile range: 5.0 weeks). The timing of RSV and influenza onsets were found to occur more synchronously in the 2023–2024 and 2024–2025 ILI seasons. The timing of COVID-19 outbreaks did not show a consistent seasonal pattern across the study period.</div></div><div><h3>Interpretation</h3><div>RSV epidemics frequently reach peak volume before influenza epidemics across the US. Healthcare professionals and public health authorities should anticipate increases in RSV cases and hospitalizations at the start of the annual ILI season and establish infrastructure and planning to handle incoming surges of both RSV and influenza appropriately.</div></div><div><h3>Funding</h3><div>CDC <span>Center for Forecasting and Outbreak Analytics</span>; <span>National Institutes of Health</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101359"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new era for RSV: the end in sight? RSV的新时代:终结在望?
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-01 DOI: 10.1016/j.lana.2025.101364
The Lancet Regional Health – Americas
{"title":"A new era for RSV: the end in sight?","authors":"The Lancet Regional Health – Americas","doi":"10.1016/j.lana.2025.101364","DOIUrl":"10.1016/j.lana.2025.101364","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"53 ","pages":"Article 101364"},"PeriodicalIF":7.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145924385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective 扩展HTLV-1超越HAM/TSP的神经谱:当代视角
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-31 DOI: 10.1016/j.lana.2025.101347
Abelardo Q.C. Araujo , Marcus Tulius T. Silva
Human T-lymphotropic virus type 1 (HTLV-1) has long been linked mainly to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, four decades of research show that the virus causes a much broader range of neurological conditions. In Latin America and the Caribbean—regions with high prevalence but limited awareness, diagnostic capacity, and treatment—its burden is especially severe. Misdiagnosis or neglect often delays care, leading to increased disability and emotional distress. This Personal View highlights the expanding neurological spectrum of HTLV-1, which includes rare but well-documented encephalopathy, cognitive decline, peripheral neuropathy, inflammatory myopathy, cerebellar dysfunction, autonomic disorders, motor neuron disease-like syndromes, and seizures. These can happen independently or alongside HAM/TSP. The proposed concept of an “HTLV-1 neurological complex” better represents this multifaceted involvement. Recognising this diversity is essential for accurate diagnosis and better outcomes, particularly in endemic settings. A paradigm shift is needed—one that broadens the clinical focus beyond myelopathy to encompass the full neurological spectrum, thereby improving global care and management.
人类嗜t淋巴病毒1型(HTLV-1)长期以来主要与HTLV-1相关的脊髓病/热带痉挛性麻痹(HAM/TSP)有关。然而,40年的研究表明,这种病毒引起的神经系统疾病范围要广得多。在拉丁美洲和加勒比- - -患病率高但认识、诊断能力和治疗有限的地区- - -其负担尤其严重。误诊或忽视往往延误护理,导致残疾和情绪困扰增加。本个人观点强调了HTLV-1不断扩大的神经谱系,包括罕见但文献充分的脑病、认知能力下降、周围神经病变、炎症性肌病、小脑功能障碍、自主神经障碍、运动神经元疾病样综合征和癫痫发作。这些可以独立发生,也可以与HAM/TSP一起发生。提出的“HTLV-1神经复合体”概念更好地代表了这种多方面的参与。认识到这种多样性对于准确诊断和获得更好的结果至关重要,特别是在流行环境中。我们需要一种模式的转变——将临床重点从脊髓病扩展到整个神经系统,从而改善全球的护理和管理。
{"title":"Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective","authors":"Abelardo Q.C. Araujo ,&nbsp;Marcus Tulius T. Silva","doi":"10.1016/j.lana.2025.101347","DOIUrl":"10.1016/j.lana.2025.101347","url":null,"abstract":"<div><div>Human T-lymphotropic virus type 1 (HTLV-1) has long been linked mainly to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, four decades of research show that the virus causes a much broader range of neurological conditions. In Latin America and the Caribbean—regions with high prevalence but limited awareness, diagnostic capacity, and treatment—its burden is especially severe. Misdiagnosis or neglect often delays care, leading to increased disability and emotional distress. This Personal View highlights the expanding neurological spectrum of HTLV-1, which includes rare but well-documented encephalopathy, cognitive decline, peripheral neuropathy, inflammatory myopathy, cerebellar dysfunction, autonomic disorders, motor neuron disease-like syndromes, and seizures. These can happen independently or alongside HAM/TSP. The proposed concept of an “HTLV-1 neurological complex” better represents this multifaceted involvement. Recognising this diversity is essential for accurate diagnosis and better outcomes, particularly in endemic settings. A paradigm shift is needed—one that broadens the clinical focus beyond myelopathy to encompass the full neurological spectrum, thereby improving global care and management.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101347"},"PeriodicalIF":7.0,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographical and racial and/or ethnic disparities in pediatric ARDS mortality in the USA, 2016–2022: a triennial national database retrospective cohort analysis 2016-2022年美国儿科ARDS死亡率的地理、种族和/或民族差异:三年一次的国家数据库回顾性队列分析
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-30 DOI: 10.1016/j.lana.2025.101355
Garrett Keim , Paula Magee , Cody Gathers , Anireddy R. Reddy , Charlotte Z. Woods-Hill , Nadir Yehya

Background

Disparities in pediatric critical care outcomes are recognized, but national data describing Pediatric Acute Respiratory Distress Syndrome (PARDS) prevalence, mortality and temporal trends are limited. We described prevalence, and regional and racial/ethnic mortality disparities for algorithm-defined ARDS, a surrogate for PARDS in US children from 2016 to 2022.

Methods

We performed a retrospective cohort study using the 2016, 2019, and 2022 Kids' Inpatient Database (KID). Algorithm-defined ARDS was identified with an ICD-10 approach requiring acute respiratory failure from pulmonary, sepsis, or shock etiologies requiring invasive mechanical ventilation ≥24 h. The primary outcome was in-hospital mortality. Exposures were US region and Race/Ethnicity, modeled individually and jointly. Mixed-effect logistic regression models, adjusting for income quartile, APR-DRG severity of illness, hospital type, and complex chronic conditions, estimated adjusted mortalities and risk differences.

Findings

Algorithm-defined ARDS occurred in about 42,000 hospitalizations per year, with prevalence increasing from 0.68% (95% CI 0.67–0.69) in 2016 to 0.75% (0.74–0.75) in 2022. Overall mortality was 12.9% (12.5–13.3) in 2016, 12.5% (12.1–12.9) in 2019, and 13.7% (13.3–14.1) in 2022. In the joint model, relative to Northeastern White children (predicted 10.9%, 95% CI 9.72–12.1), risks were higher for Black children in the South (predicted 14.2%, ARD 3.27%, 1.74–4.79) and West (14.6%, ARD 3.69%, 1.39–6.00); Hispanic children in the West (12.6%, ARD 1.70%, 0.09–3.31), and children of Other race/ethnicity in the South (16.5%, ARD 5.57%, 3.14–7.99) and West (14.0%, ARD 3.11%, 0.96–5.25). Disparities did not meaningfully change from 2016 to 2019, while mortality increased from 2019 to 2022.

Interpretation

Algorithm-defined ARDS among hospitalized US children remains common and highly fatal. Persistent regional and racial/ethnic disparities highlight systemic drivers of inequity and the need for targeted interventions.

Funding

This work was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (Award K23HL177271, PI: Keim).
背景:儿童重症监护结果的差异是公认的,但描述儿童急性呼吸窘迫综合征(PARDS)患病率、死亡率和时间趋势的国家数据是有限的。我们描述了2016年至2022年美国儿童中算法定义的ARDS (PARDS的替代方法)的患病率、地区和种族/民族死亡率差异。方法采用2016年、2019年和2022年儿童住院患者数据库(KID)进行回顾性队列研究。通过ICD-10方法确定算法定义的ARDS,要求肺部、败血症或休克病因引起的急性呼吸衰竭需要有创机械通气≥24小时。主要结局是院内死亡率。暴露是美国地区和种族/民族,单独和联合建模。混合效应logistic回归模型,调整了收入四分位数、疾病的APR-DRG严重程度、医院类型和复杂慢性病,估计了调整后的死亡率和风险差异。算法定义的ARDS发生在每年约42,000例住院患者中,患病率从2016年的0.68% (95% CI 0.67-0.69)增加到2022年的0.75%(0.74-0.75)。2016年总死亡率为12.9%(12.5-13.3),2019年为12.5%(12.1-12.9),2022年为13.7%(13.3-14.1)。在联合模型中,相对于东北部白人儿童(预测10.9%,95% CI 9.72-12.1),南部黑人儿童(预测14.2%,ARD 3.27%, 1.74-4.79)和西部黑人儿童(14.6%,ARD 3.69%, 1.39-6.00)的风险更高;西部的西班牙裔儿童(12.6%,ARD 1.70%, 0.09-3.31),南部(16.5%,ARD 5.57%, 3.14-7.99)和西部(14.0%,ARD 3.11%, 0.96-5.25)的其他种族/族裔儿童。从2016年到2019年,差距没有显著变化,而死亡率从2019年到2022年有所上升。解释算法定义的急性呼吸窘迫综合征在美国住院儿童中仍然很常见且高度致命。持续存在的区域和种族/族裔差异突出了不平等的系统性驱动因素和有针对性干预措施的必要性。本研究得到了美国国立卫生研究院国家心肺血液研究所的支持(编号:K23HL177271, PI: Keim)。
{"title":"Geographical and racial and/or ethnic disparities in pediatric ARDS mortality in the USA, 2016–2022: a triennial national database retrospective cohort analysis","authors":"Garrett Keim ,&nbsp;Paula Magee ,&nbsp;Cody Gathers ,&nbsp;Anireddy R. Reddy ,&nbsp;Charlotte Z. Woods-Hill ,&nbsp;Nadir Yehya","doi":"10.1016/j.lana.2025.101355","DOIUrl":"10.1016/j.lana.2025.101355","url":null,"abstract":"<div><h3>Background</h3><div>Disparities in pediatric critical care outcomes are recognized, but national data describing Pediatric Acute Respiratory Distress Syndrome (PARDS) prevalence, mortality and temporal trends are limited. We described prevalence, and regional and racial/ethnic mortality disparities for algorithm-defined ARDS, a surrogate for PARDS in US children from 2016 to 2022.</div></div><div><h3>Methods</h3><div>We performed a retrospective cohort study using the 2016, 2019, and 2022 Kids' Inpatient Database (KID). Algorithm-defined ARDS was identified with an ICD-10 approach requiring acute respiratory failure from pulmonary, sepsis, or shock etiologies requiring invasive mechanical ventilation ≥24 h. The primary outcome was in-hospital mortality. Exposures were US region and Race/Ethnicity, modeled individually and jointly. Mixed-effect logistic regression models, adjusting for income quartile, APR-DRG severity of illness, hospital type, and complex chronic conditions, estimated adjusted mortalities and risk differences.</div></div><div><h3>Findings</h3><div>Algorithm-defined ARDS occurred in about 42,000 hospitalizations per year, with prevalence increasing from 0.68% (95% CI 0.67–0.69) in 2016 to 0.75% (0.74–0.75) in 2022. Overall mortality was 12.9% (12.5–13.3) in 2016, 12.5% (12.1–12.9) in 2019, and 13.7% (13.3–14.1) in 2022. In the joint model, relative to Northeastern White children (predicted 10.9%, 95% CI 9.72–12.1), risks were higher for Black children in the South (predicted 14.2%, ARD 3.27%, 1.74–4.79) and West (14.6%, ARD 3.69%, 1.39–6.00); Hispanic children in the West (12.6%, ARD 1.70%, 0.09–3.31), and children of Other race/ethnicity in the South (16.5%, ARD 5.57%, 3.14–7.99) and West (14.0%, ARD 3.11%, 0.96–5.25). Disparities did not meaningfully change from 2016 to 2019, while mortality increased from 2019 to 2022.</div></div><div><h3>Interpretation</h3><div>Algorithm-defined ARDS among hospitalized US children remains common and highly fatal. Persistent regional and racial/ethnic disparities highlight systemic drivers of inequity and the need for targeted interventions.</div></div><div><h3>Funding</h3><div>This work was supported by the <span>National Heart, Lung, and Blood Institute, National Institutes of Health</span> (Award K23HL177271, PI: Keim).</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"54 ","pages":"Article 101355"},"PeriodicalIF":7.0,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145884484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncovering the biases: why the claimed mask–excess mortality link fails to hold 揭露偏见:为什么声称的口罩与死亡率过高的联系站不住脚
IF 7 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-12-29 DOI: 10.1016/j.lana.2025.101360
Thiago Cerqueira-Silva , Felipe Argolo , Gabriel Gonçalves da Costa , Felipe Nogueira Barbara , Pedro Hallal , Bruno Gualano
{"title":"Uncovering the biases: why the claimed mask–excess mortality link fails to hold","authors":"Thiago Cerqueira-Silva ,&nbsp;Felipe Argolo ,&nbsp;Gabriel Gonçalves da Costa ,&nbsp;Felipe Nogueira Barbara ,&nbsp;Pedro Hallal ,&nbsp;Bruno Gualano","doi":"10.1016/j.lana.2025.101360","DOIUrl":"10.1016/j.lana.2025.101360","url":null,"abstract":"","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"55 ","pages":"Article 101360"},"PeriodicalIF":7.0,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145885804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Regional Health-Americas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1